Skip to main content Accessibility help
×
Hostname: page-component-848d4c4894-mwx4w Total loading time: 0 Render date: 2024-06-28T15:35:24.415Z Has data issue: false hasContentIssue false

2 - Researching the mechanisms underlying the symptoms of patients with cancer

from Section 1 - Introduction

Published online by Cambridge University Press:  05 August 2011

Adrian J. Dunn
Affiliation:
University of Hawaii at Manoa
Charles S. Cleeland
Affiliation:
University of Texas, M. D. Anderson Cancer Center
Michael J. Fisch
Affiliation:
University of Texas, M. D. Anderson Cancer Center
Adrian J. Dunn
Affiliation:
University of Hawaii, Manoa
Get access

Summary

The overarching goals of the science of symptom research are to prevent the development of symptoms and to establish new or enhanced treatment methods for the symptoms of cancer and cancer treatment, which may in turn lead to improvement in patient function, stress level, satisfaction with and willingness to endure therapy, and quality of life both during and after cancer treatment. To design treatments for the symptoms experienced by patients with cancer, it would be extremely useful to know the underlying mechanisms of those symptoms. In many areas of medicine, animal models have proven useful for suggesting underlying mechanisms of diseases and for testing appropriate therapies.

In this chapter we briefly discuss the theories underlying the use of animal models in cancer symptom research.Chapter 3 builds on this foundation with a review of animal research that may be appropriate for modeling the symptoms associated with cancer and its treatment.

The rationale for animal models

Using animal models in research

In principle, animal models can be used to mimic certain disease states, to identify potential underlying mechanisms and to test potential therapies – pharmacological, surgical, or otherwise. Th e primary rationale for using animal models is that certain exp erimental procedures are diffi cult to perform or would be considered unethical to perform in humans.

Type
Chapter
Information
Cancer Symptom Science
Measurement, Mechanisms, and Management
, pp. 4 - 7
Publisher: Cambridge University Press
Print publication year: 2010

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Shaywitz, BA, Klopper, JH, Yager, RD, Gordon, JW. Paradoxical response to amphetamine in developing rats treated with 6-hydroxydopamine. Nature 261(5556):153–155, 1976.CrossRefGoogle ScholarPubMed
Hart, BL. Biological basis of the behavior of sick animals. Neurosci Biobehav Rev 12(2):123–137, 1988.CrossRefGoogle ScholarPubMed
Selye, H. The Stress of My Life: a Scientist's Memoirs, with a 32-page section of photographs, 2nd ed. New York: Van Nostrand Reinhold, 1979.Google Scholar
Yirmiya, R, Avitsur, R, Donchin, O, Cohen, E. Interleukin-1 inhibits sexual behavior in female but not in male rats. Brain Behav Immun 9(3):220–233, 1995.CrossRefGoogle ScholarPubMed
Vollmer-Conna, U, Fazou, C, Cameron, B, et al. Production of pro-inflammatory cytokines correlates with the symptoms of acute sickness behaviour in humans. Psychol Med 34(7):1289–1297, 2004.CrossRefGoogle ScholarPubMed
Blatteis, CM, Sehic, E. Cytokines and fever. Ann N Y Acad Sci 840:608–618, 1998.CrossRefGoogle ScholarPubMed
Dantzer, R, Kelley, KW. Twenty years of research on cytokine-induced sickness behavior. Brain Behav Immun 21(2):153–160, 2007.CrossRefGoogle ScholarPubMed
Larson, SJ, Dunn, AJ. Behavioral effects of cytokines. Brain Behav Immun 15(4):371–387, 2001.CrossRefGoogle ScholarPubMed
Dunn, AJ. Effects of cytokines and infections on brain neurochemistry. In: Ader, R, Felten, DL, Cohen, N, eds. Psychoneuroimmunology. San Diego, CA: Academic Press, 2001:649–686.Google Scholar
Krueger, JM, Majde, JA. Microbial products and cytokines in sleep and fever regulation. Crit Rev Immunol 14(3–4):355–379, 1994.CrossRefGoogle ScholarPubMed
Otterness, IG, Seymour, PA, Golden, HW, Reynolds, JA, Daumy, GO. The effects of continuous administration of murine interleukin-1 alpha in the rat. Physiol Behav 43(6):797–804, 1988.CrossRefGoogle ScholarPubMed
McCarthy, , Kluger, MJ, Vander, AJ. Suppression of food intake during infection: is interleukin-1 involved?Am J Clin Nutr 42(6):1179–1182, 1985.CrossRefGoogle ScholarPubMed
Dunn, AJ, Chapman, Y, Antoon, M. Endotoxin-induced behavioral changes of mice in the multicompartment chamber are distinct from those of interleukin-1. Neurosci Res Commun 10:63–69, 1992.Google Scholar
Lacosta, S, Merali, Z, Anisman, H. Influence of interleukin-1beta on exploratory behaviors, plasma ACTH, corticosterone, and central biogenic amines in mice. Psychopharmacology (Berl) 137(4):351–361, 1998.CrossRefGoogle ScholarPubMed
Spadaro, F, Dunn, AJ. Intracerebroventricular administration of interleukin-1 to mice alters investigation of stimuli in a novel environment. Brain Behav Immun 4(4):308–322, 1990.CrossRefGoogle Scholar
Dantzer, R, Bluthé, RM, Castanon, N, et al. Cytokine effects on behavior. In: Ader, R, Felten, DL, Cohen, N, eds. Psychoneuroimmunology. San Diego, CA: Academic Press, 2001:703–727.Google Scholar
Avitsur, R, Donchin, O, Barak, O, Cohen, E, Yirmiya, R. Behavioral effects of interleukin-1 beta: modulation by gender, estrus cycle, and progesterone. Brain Behav Immun 9(3):234–241, 1995.CrossRefGoogle ScholarPubMed
Kent, S, Bluthé, RM, Kelley, KW, Dantzer, R. Sickness behavior as a new target for drug development. Trends Pharmacol Sci 13(1):24–28, 1992.CrossRefGoogle ScholarPubMed
Pugh, CR, Fleshner, M, Watkins, LR, Maier, SF, Rudy, JW. The immune system and memory consolidation: a role for the cytokine IL-1 beta. Neurosci Biobehav Rev 25(1):29–41, 2001.CrossRefGoogle Scholar
Larson, SJ, Romanoff, RL, Dunn, AJ, Glowa, JR. Effects of interleukin-1beta on food-maintained behavior in the mouse. Brain Behav Immun 16(4):398–410, 2002.CrossRefGoogle ScholarPubMed
Raison, CL, Capuron, L, Miller, AH. Cytokines sing the blues: inflammation and the pathogenesis of depression. Trends Immunol 27(1):24–31, 2006.CrossRefGoogle Scholar
Stack, WA, Mann, SD, Roy, AJ, et al. Randomised controlled trial of CDP571 antibody to tumour necrosis factor-alpha in Crohn's disease. Lancet 349(9051):521–524, 1997.CrossRefGoogle ScholarPubMed
Taylor, PC. Anti-TNFalpha therapy for rheumatoid arthritis: an update. Intern Med 42(1):15–20, 2003.CrossRefGoogle ScholarPubMed
Maes, M. Evidence for an immune response in major depression: a review and hypothesis. Prog Neuropsychopharmacol Biol Psychiatry 19(1):11–38, 1995.CrossRefGoogle ScholarPubMed

Save book to Kindle

To save this book to your Kindle, first ensure coreplatform@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about saving to your Kindle.

Note you can select to save to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be saved to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

Find out more about the Kindle Personal Document Service.

Available formats
×

Save book to Dropbox

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Dropbox.

Available formats
×

Save book to Google Drive

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Google Drive.

Available formats
×